24 Apr 2026
33m
9 Mio. € Seed Pre-Product: Krebs per Shuttle-Technologie behandeln – Marcus Kostka (iDEL Therapeutics)
Startup Insider
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.